Fri, Mar 6, 2015, 12:04 AM EST - U.S. Markets open in 9 hrs 26 mins


% | $
Quotes you view appear here for quick access.

Genomic Health Inc. Message Board

  • terry_amln terry_amln Aug 8, 2014 9:03 AM Flag

    Ramping up new markets

    In the second quarter of 2014, we delivered record revenue with 17% growth in test volume and double-digit revenue growth. This impressive result was achieved by continuing to increase penetration of the U.S. invasive breast cancer market, as well as continued international adoption and reimbursement success. Further, we recently announced positive results from 2 additional large clinical validation studies in DCIS breast cancer and prostate cancer, both of which are large new markets representing nearly 200,000 patients in the U.S. alone each year.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • He is really id terry_insm or terry_amln, califfla and many others. He is really Terence Dan Mooney, 1633 Diamond ST San Diego, CA 92109 Terry lives alone in San Diego his wife (Linda Mooney) lives in NC and Vir. in the nursing field. Their daughter Melissa Mooney (37) lives near her mom. Terry lives on the computer with very little life beyond that world. It is the old sad story of the guy in the basement with no life. In this case he lives in an apartment. He lives off SS and day trading. Net Worth $200+- DOB Aug 7th, 1948. He has lived in San Diego Bainbridge Island, WA, Largo, FL, Clearwater, FL and Purcellville, VA. Now you know why the name “califfla” was formed.

    • we are pleased to report prostate test adoption accelerated at a strong pace resulting in a 54% increase in test volume compared with the first quarter of 2014. To date, approximately 900 urologists have ordered the Oncotype DX prostate cancer test, up 30% compared to the prior quarter, and more than half of these physicians have now ordered tests for multiple patients. We believe these results demonstrate physicians' recognition of the clinical value of Oncotype DX, the only prostate cancer test developed for low and intermediate risk patients, those most likely suitable for active surveillance.

32.33+1.2500(+4.02%)Mar 5 4:00 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Geron Corporation
NASDAQThu, Mar 5, 2015 4:00 PM EST
AbbVie Inc.
NYSEThu, Mar 5, 2015 4:02 PM EST
YY Inc.
NASDAQThu, Mar 5, 2015 4:00 PM EST